Patent · US Active

Compounds

US7678801B2 · kind B2 · utility

0Cited by
31References
76Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 24, 2006
Grant dateMar 16, 2010
Priority date—
Expiry dateOct 20, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds and compositions, and their use use in therapy as CSBP/RK/p38 kinase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.